Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - CardioGenics Holdings Inc. | v333216_10k.htm |
| EX-31.1 - EXHIBIT 31.1 - CardioGenics Holdings Inc. | v333216_ex31-1.htm |
| EX-23.2 - EXHIBIT 23.2 - CardioGenics Holdings Inc. | v333216_ex23-2.htm |
| EX-23.1 - EXHIBIT 23.1 - CardioGenics Holdings Inc. | v333216_ex23-1.htm |
| EX-32.1 - EXHIBIT 32.1 - CardioGenics Holdings Inc. | v333216_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - CardioGenics Holdings Inc. | v333216_ex31-2.htm |
Exhibit 23.3
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-137162) of CardioGenics Holdings Inc. of our report dated July 29, 2009 relating to the consolidated balance sheet of CardioGenics Holdings In. [formerly CardioGenics Inc., (a development stage company)], as of October 31, 2008 and the related consolidated statements of operations, stockholders’ equity (deficit) and cash flows for the year then ended, which appears in this Annual Report on Form 10-K. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
(signed) “BDO Canada LLP”
Chartered Accountants, Licensed Public Accountants
Toronto, Ontario, Canada
January 29, 2013